UBS AM’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.04M | Sell |
|
|||||
|
2025
Q1 | $62M | Buy |
|
|||||
|
2024
Q4 | $30.4M | Buy |
|
|||||
|
2024
Q3 | $43.4M | Sell |
|
|||||
|
2024
Q2 | $37.5M | Buy |
|
|||||
|
2024
Q1 | $5.05M | Buy |
|
|||||
|
2023
Q4 | $7.44M | Sell |
|
|||||
|
2023
Q3 | $5.52M | Sell |
|
|||||
|
2023
Q2 | $7.48M | Hold |
|
|||||
|
2023
Q1 | $7.48M | Buy |
|
|||||
|
2022
Q4 | $4.68M | Sell |
|
|||||
|
2022
Q3 | $3.69M | Sell |
|
|||||
|
2022
Q2 | $20.8M | Sell |
|
|||||
|
2022
Q1 | $42.2M | Buy |
|
|||||
|
2021
Q4 | $74.1M | Sell |
|
|||||
|
2021
Q3 | $76.9M | Buy |
|
|||||
|
2021
Q2 | $101M | Buy |
|
|||||
|
2021
Q1 | $90.1M | Sell |
|
|||||
|
2020
Q4 | $87.9M | Buy |
|
|||||
|
2020
Q3 | $54.9M | Buy |
|
|||||
|
2020
Q2 | $35.3M | Buy |
|
|||||
|
2020
Q1 | $22.6M | Buy |
|
|||||
|
2019
Q4 | $27.6M | Buy |
|
|||||
|
2019
Q3 | $9.31M | Buy |
|